Its at interesting level (.5c). Any positives for buy/accumulate? Or any more negatives to pressure the SP at these level?
Positives:
- FID buying
- Possible non-US roll out - Even this is in works, it is miles away
Anything coming or what to look for this year 2017?
- Forums
- ASX - By Stock
- YOW
- Director Remuneration
Director Remuneration, page-31
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add YOW (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.734M |
Open | High | Low | Value | Volume |
2.5¢ | 2.5¢ | 2.5¢ | $1K | 40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 46278 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 1309 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 46278 | 0.025 |
4 | 143494 | 0.023 |
1 | 45499 | 0.022 |
1 | 95383 | 0.021 |
1 | 250000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 1309 | 1 |
0.028 | 50000 | 2 |
0.030 | 38056 | 1 |
0.034 | 19500 | 1 |
0.036 | 333333 | 1 |
Last trade - 12.46pm 15/07/2024 (20 minute delay) ? |
Featured News
YOW (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online